Cargando…

1391. Vancomycin Area Under the Curve (AUC) to Predict Nephrotoxicity: A Systematic Review and Meta-Analysis of Observational Studies

BACKGROUND: Recent studies have proposed monitoring vancomycin area under the curve (AUC) as a more precise method of attaining goal exposures compared with trough monitoring. Different dosing methods and different exposure-toxicity thresholds have been proposed. Therefore, we aimed to analyze the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aljefri, Doaa, Avedissian, Sean, Rhodes, Nathaniel J, Postelnick, Michael, Scheetz, Marc H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252793/ http://dx.doi.org/10.1093/ofid/ofy210.1222

Ejemplares similares

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1821. Understanding the Components and Calculation of the SAAR, Illustrative Data
por: Avedissian, Sean, et al.
Publicado: (2018)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

1097. A Comparison of Area-Under Curve (AUC)-Guided vs Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-analysis
por: Lim, Ashley Shiyuan, et al.
Publicado: (2021)

598. Area under the curve-guided vancomycin monitoring and risk of nephrotoxicity in non-Staphylococcus aureus infections: A case-control study
por: Mazewski, Douglas, et al.
Publicado: (2022)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
por: Sujjavorakul, Kritsaporn, et al.
Publicado: (2023)

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring
por: Ugi, Satoshi, et al.
Publicado: (2016)

Successful Treatment of Invasive MRSA Infections in Children Using Area Under the Vancomycin Concentration-Time Curve Divided by the Minimum Inhibitory Concentration (AUC/MIC) to Measure Vancomycin Exposure
por: Chiang, Leslie, et al.
Publicado: (2021)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

In Outpatients Receiving Parenteral Vancomycin, Dosing Adjustments Produced by Area Under the Curve-Based and Trough-Based Monitoring Differ Only at the Extremes of the Therapeutic Trough Range
por: Shi, Yufei, et al.
Publicado: (2023)

A modified Wald interval for the area under the ROC curve (AUC) in diagnostic case-control studies
por: Kottas, Martina, et al.
Publicado: (2014)

1326. Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
por: Pearson, Jeffrey, et al.
Publicado: (2020)

In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
por: Papp, Nicole, et al.
Publicado: (2022)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

The Nephrotoxicity of Vancomycin
por: Filippone, EJ, et al.
Publicado: (2017)

Area-Under-Curve–Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis
por: Lim, Ashley Shiyuan, et al.
Publicado: (2023)

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
por: Avedissian, Sean N., et al.
Publicado: (2019)

1394. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid (CSF) and Plasma Concentrations of Cefepime
por: Liu, Jiajun, et al.
Publicado: (2018)

Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis
por: Chiu, Chia-Yu, et al.
Publicado: (2023)

Vancomycin area under the curve-guided monitoring in pediatric patients
por: Morales Junior, Ronaldo, et al.
Publicado: (2022)

349. The impact of Vancomycin dosing by area under the curve over minimal inhibitory concentration (AUC/MIC) versus Trough levels on cumulative Vancomycin dosage and incidence of Acute Kidney Injury (AKI) in patients admitted to intensive care units (ICU)
por: Sahu, Aniruddha, et al.
Publicado: (2023)

Impact of Area Under the Concentration-Time Curve-Guided Monitoring on Vancomycin Nephrotoxicity and Treatment Outcomes in Methicillin-Resistant Staphylococcus Aureus Bacteremia in Korean Patients
por: Kim, Young Rong, et al.
Publicado: (2022)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022)

Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
por: Tantranont, Ngoentra, et al.
Publicado: (2021)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
por: Markoski, Nikola, et al.
Publicado: (2019)

Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Lodise, Thomas P, et al.
Publicado: (2022)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

A Review of the Clinical Pharmacokinetics of Polymyxin B
por: Avedissian, Sean N., et al.
Publicado: (2019)

1569. A Translational Model to Assess the Impact of Polymyxin B Dose Fractionation on Kidney Injury
por: Liu, Jiajun, et al.
Publicado: (2019)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study
por: Liu, Jiajun, et al.
Publicado: (2020)

1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
por: Avedissian, Sean, et al.
Publicado: (2018)

Therapeutic drug monitoring of vancomycin by AUC(τ)-MIC ratio in patients with chronic kidney disease
por: Khoei, Ahmad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_67h1iqbb6nk20ikvdgu6bg7cg6